Colorectal cancer survivors who maintained a stable body weight but lost muscle and developed fatty deposits in their muscles faced
Continue reading »
Home »
Colorectal cancer risk remains despite modern treatment for ulcerative colitis
Patients with the inflammatory bowel disease ulcerative colitis have a higher risk of dying from colorectal cancer, despite modern therapy,
Continue reading »
A novel pathway to target colorectal cancer
While the emergence of precision medicine and immunotherapy has greatly improved outcomes for patients with colorectal cancer, new approaches are
Continue reading »
Colorectal neoplasia risk up for Hodgkin Lymphoma survivors
(HealthDay)—Hodgkin lymphoma (HL) survivors have an increased risk for advanced colorectal neoplasia, including advanced adenomas, advanced serrated lesions, and serrated
Continue reading »
High-dose vitamin D shows benefit in patients with advanced colorectal cancer
Results of a small clinical trial suggest that supplementing chemotherapy with high doses of vitamin D may benefit patients with
Continue reading »
Opdivo (nivolumab) + Low-Dose Yervoy (ipilimumab) Combination Approved for Previously Treated MSI-H/dMMR Metastatic Colorectal Cancer
PRINCETON, N.J.– July 11, 2018 (BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE: BMY) today announced Opdivo (nivolumab) 3 mg/kg plus low-dose Yervoy
Continue reading »
As colorectal cancer rises in young people, new guidelines recommend screening start at 45
The American Cancer Society (ACS) and other preventive guideline organizations recommend that screening for colorectal cancer start for people of
Continue reading »
DNA-based vaccine treatment for colorectal cancer to undergo first human study
For the first time in humans, researchers will test a two-pronged approach to treat advanced stage colorectal cancer (CRC), potentially
Continue reading »